TABLE 3
FROM:
A Double-Blind, Placebo-Controlled Trial of Modafinil for Cocaine Dependence
Charles A Dackis, Kyle M Kampman, Kevin G Lynch, Helen M Pettinati and Charles P O'Brien
BACK TO ARTICLETable 3. Estimated Probabilities of an Abstinent Visit at the Beginning, Middle, and End of the 8-Week Trial for the Placebo and Modafinil Groups, According to Baseline BE Status
| Tx group; baseline BE status | Week 1 | Week 5 | Week 8 |
|---|---|---|---|
| Placebo; BE-negative | 0.68 | 0.46 | 0.56 |
| Modafinil; BE-negative | 0.64 | 0.61 | 0.45 |
| Placebo; BE-positive | 0.13 | 0.19 | 0.14 |
| Modafinil; BE-positive | 0.11 | 0.30 | 0.10 |
